弥散加权成像eADC值在鉴别诊断前列腺良恶性结节中的应用价值(4)
[14] Wu X，Reinikainen P，Kapanen M，et al. Diffusion-weighted MRI Provides a Useful Biomarker for Evaluation of Radiotherapy Efficacy in Patients with Prostate Cancer[J]. Anticancer Res，2017，37(9)：5027-5032.
[15] Lee DH，Nam JK，Jung HS，et al. Does T1- and diffusion-weighted magnetic resonance imaging give value-added than bone scintigraphy in the follow-up of vertebral metastasis of prostate cancer？ [J]. Investig Clin Urol，2017，58(5)：324-330.
[16] Barbieri S，Br？觟nnimann M，Boxler S，et al. Differentiation of prostate cancer lesions with high and with low Gleason score by diffusion-weighted MRI [J]. Eur Radiol，2017， 27(4)：1547-1555.
[17] Scialpi M，Martorana E，Aisa MC，et al. Score 3 prostate lesions： a gray zone for PI-RADS v2[J]. Turk J Urol，2017，43(3)：237-240.
[18] Zhang YL，Yu BL，Ren J，et al. EADC Values in Diagnosis of Renal Lesions by 3.0T Diffusion-Weighted Magnetic Resonance Imaging：Compared with the ADC Values [J]. Appl Magn Reson，2013，44(3)：349-363.
[19] Cou？觡ago F， Sancho G，Catalá V，et al. Magnetic resonance imaging for prostate cancer before radical and salvage radiotherapy：What radiation oncologists need to know [J]. World Journal of Clinical Oncology，2017，8(4)：305-319.
[20] Zhou H，Hallac RR，Yuan Q，et al. Incorporating Oxygen-Enhanced MRI into Multi-Parametric Assessment of Human Prostate Cancer [J]. Diagnostics(Basel)，2017，7(3)：pii：E48.
(收稿日期：2019-08-14 本文編辑：顾家毓), http://www.100md.com(刘三春 祁英 周之怀)
[15] Lee DH，Nam JK，Jung HS，et al. Does T1- and diffusion-weighted magnetic resonance imaging give value-added than bone scintigraphy in the follow-up of vertebral metastasis of prostate cancer？ [J]. Investig Clin Urol，2017，58(5)：324-330.
[16] Barbieri S，Br？觟nnimann M，Boxler S，et al. Differentiation of prostate cancer lesions with high and with low Gleason score by diffusion-weighted MRI [J]. Eur Radiol，2017， 27(4)：1547-1555.
[17] Scialpi M，Martorana E，Aisa MC，et al. Score 3 prostate lesions： a gray zone for PI-RADS v2[J]. Turk J Urol，2017，43(3)：237-240.
[18] Zhang YL，Yu BL，Ren J，et al. EADC Values in Diagnosis of Renal Lesions by 3.0T Diffusion-Weighted Magnetic Resonance Imaging：Compared with the ADC Values [J]. Appl Magn Reson，2013，44(3)：349-363.
[19] Cou？觡ago F， Sancho G，Catalá V，et al. Magnetic resonance imaging for prostate cancer before radical and salvage radiotherapy：What radiation oncologists need to know [J]. World Journal of Clinical Oncology，2017，8(4)：305-319.
[20] Zhou H，Hallac RR，Yuan Q，et al. Incorporating Oxygen-Enhanced MRI into Multi-Parametric Assessment of Human Prostate Cancer [J]. Diagnostics(Basel)，2017，7(3)：pii：E48.
(收稿日期：2019-08-14 本文編辑：顾家毓), http://www.100md.com(刘三春 祁英 周之怀)